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Exploring the hyperpolarisation of EGTA-based
ligands using SABRE†
Ben. J. Tickner, ‡§a Yulia Borozdina,‡b Simon B. Duckett *a and
Goran Angelovski *b,c
The design of molecules whose magnetic resonance (MR) signals report on their biological environment
is receiving attention as a route to non-invasive functional MR. Hyperpolarisation techniques improve the
sensitivity of MR and enable real time low concentration MR imaging, allowing for the development of
novel functional imaging methodologies. In this work, we report on the synthesis of a series of EGTA-
derived molecules (EGTA – ethylene glycol-bis(2-aminoethylether)-N,N,N’,N’-tetraacetic acid), whose
core structures are known to bind biologically relevant metal ions in vivo, in addition to pyridyl rings that
allow reversible ligation to an iridium dihydride complex. Consequently, they are amenable to hyperpolar-
isation through the parahydrogen-based signal amplification by reversible exchange (SABRE) process. We
investigate how the proximity of EGTA and pyridine units, and the identity of the linker group, affect the
SABRE hyperpolarisation attained for each agent. We also describe the effect of catalyst identity and co-
ligand presence on these measurements and can achieve 1H NMR signal enhancements of up to
160-fold. We rationalise these results to suggest the design elements needed for probes amenable to
SABRE hyperpolarisation whose MR signals might in the future report on the presence of metal ions.
Introduction
Many spectroscopic techniques have been developed to study
the chemical structures of molecules and the morphology of
materials. These include the development of methods that rely
on the principles of magnetic resonance (MR) to probe nuclear
spin without the need for approaches based on ionising radi-
ation such as X-ray, computed or positron emission tomogra-
phy (CT or PET respectively), or sample destruction as in mass
spectrometry. These advantages have led to magnetic reso-
nance imaging (MRI) becoming routine for the diagnosis of
structural abnormalities in living tissue.
Despite the diversity of its successes, MR is insensitive at
the molecular level as the detected signal relies on small
Boltzmann derived population differences across closely
spaced nuclear spin energy levels. In fact, only around 1 in
every 195 000 1H nuclei contribute positively to an MR signal
recorded in a 1.5 T field common for clinical MRI scanners. It
is not surprising therefore that MRI is usually concerned with
detection of highly concentrated species, such as bulk water.
Nevertheless, images with anatomical contrast can be pro-
duced by T1 or T2 weighted sequences to differentiate tissue
morphologies. The information content of these approaches is
often improved by the injection of a paramagnetic contrast
agent.1 However, as such images normally convey little direct
information about biological function, there are opportunities
to improve the diagnostic ability of MRI.
Many researchers are attempting to achieve this using bio-
logically induced changes in the bulk water signal intensity.2,3
Among these are approaches such as functional MRI (fMRI),
which attempts to probe the bulk water response as a function
of the oxygenation state of haemoglobin,4 or chemical
exchange saturation transfer (CEST), which modulates bulk
water signals via proton exchange with an injected CEST
agent.5 More recently, specific types of MRI contrast agents
have been developed, being responsive to metal ions6 (Ca2+,
K+, Mg2+, Zn2+ Fe2+, Fe3+, Cu2+ and others), neurotransmitters7
and proteins.8 The use of functional reporters that are able to
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respond to such changes may therefore have benefit in study-
ing different biological processes in a non-invasive way.
Approaches that target Ca2+, both intracellular and extra-
cellular, could have remarkable impact in neuroimaging due
to the essential role of this ion in neuronal signalling.9 Other
physiological processes that depend on Ca2+ could also be fol-
lowed in real-time by means of MRI.10 For this approach to
work, the preparation of appropriate functional markers is
necessary and consequently, different types of Ca-responsive
agents have been developed to date.11,12 Such reporters often
consist of paramagnetic chelates coupled to a calcium sensing
unit via a suitable linker.11 Conformational changes in the
agent upon metal ion binding are used to increase the inner
sphere hydration of the paramagnetic ions, most commonly
gadolinium, thereby enhancing the agent’s relaxivity and sub-
sequently increasing the intensity of the MRI signal in T1
weighted images.12
While these functional imaging approaches have achieved
great success, they do not fully address the low sensitivity of
MRI. Over recent years, hyperpolarisation has been used to
produce contrast agents with MR signals whose intensity is
enhanced by up to five orders of magnitude relative to those
derived from Boltzmann laws.13 With these hyperpolarised
agents, successful imaging of low concentration biomolecules,
drugs and metabolites in vivo was accomplished.13–15 While
there are several possible experimental techniques for the pro-
duction of hyperpolarised contrast agents, dissolution
dynamic nuclear polarisation (d-DNP) has achieved the most
success and a growing range of clinical applications are devel-
oping.13 However, d-DNP uses complex experimental apparatus
to transfer polarisation from electrons to nuclei over a
period of tens of minutes to several hours. The d-DNP pro-
cedure involves microwave irradiation of a target agent and
organic radical in a 1–10 T field at temperatures between 1
and 5 K before rapid sample melting and transfer into the
detection system.13 d-DNP hyperpolarisation has yielded 13C
polarisation levels of up to 70% for pyruvate-1-[13C] 14 and its
subsequent metabolic imaging can identify cancer in humans
in vivo.15
An alternative hyperpolarisation method uses parahydrogen
(pH2), the antisymmetric nuclear spin isomer of dihydrogen,
as its source of polarisation. pH2 reflects a potentially cheaper
and faster route to a hyperpolarised contrast agent for in vivo
injection and detection.16 Hydrogen gas exists as 25% pH2 at
room temperature with the remaining 75% consisting of ortho-
hydrogen. H2 can easily be enriched in the para state (>98%)
by cooling to low temperature (28 K) in the presence of a spin
exchange catalyst.17 While pH2 is NMR silent, its latent hyper-
polarisation is typically unlocked in a hydrogenation reac-
tion.13 Consequently, pH2 induced hyperpolarisation (PHIP)
usually requires unsaturated functionality within the target
agent.16 This can be alleviated by using a non-hydrogenative
variant of PHIP, called signal amplification by reversible
exchange (SABRE), which relies on a catalytic process to trans-
fer pH2 derived spin order to a target molecule.
18 While SABRE
is clearly at a much earlier stage in its development than DNP,
the simplicity of this approach suggest that its potential clini-
cal use is highly desirable. This can be highlighted by the fact
that SABRE works in seconds by creating an iridium-based
active polarisation transfer complex, which exchanges both
pH2 and a target substrate (Scheme 1).
Hyperpolarisation transfer is catalytic at low magnetic field
(∼65 G 18 or 1–10 mG 19,20 for transfer to 1H or 13C/15N nuclei
respectively) from the pH2 derived hydride ligands in the cata-
lyst to its bound target ligands through the associated
J-coupling network. Subsequent ligand dissociation allows the
build-up of chemically unchanged and yet hyperpolarised
molecules in solution before their magnetisation decays slowly
under relaxation back to the Boltzmann derived state. One of
the most common substrates reported for hyperpolarisation
using SABRE is the N-heterocycle pyridine and its
derivatives.18,20–23 Indeed, pyridine was one of the first mole-
cules to be hyperpolarised using SABRE18 and exhibits appro-
priate exchange kinetics to allow efficient polarisation transfer
within the active [Ir(H)2(NHC)(pyridine)3]Cl catalyst, where
NHC is an N-heterocyclic carbene.24 SABRE has achieved up to
65% 1H,22 4% 13C 25 and 79% 15N 26 polarisation for
N-heterocycles, although other functionalities including
Scheme 1 SABRE involves the in situ formation of active polarisation transfer catalysts that reversibly exchange both pH2 and substrate (Sub). Such
species are typically of the type [Ir(H)2(NHC)(Sub)3]Cl where NHC is an N-heterocyclic carbene and are formed from the reaction of an iridium pre-
catalyst with substrate and H2. Magnetisation is catalytically transferred from pH2 derived hydride ligands to ligated substrate at an optimum mag-
netic field. Typical substrate molecules contain N-, O- or S-donor groups. In this work, Sub contains an iridium binding and EGTA-derived motif sep-
arated by a linker (Fig. 1). We also show the structures of the NHC ligands for the iridium precatalysts used in this work.
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nitriles,27 amines28 and even O-donors pyruvate19 and
acetate29 can be hyperpolarised by SABRE. Relayed proton
exchange effects are now expanding the scope to include non-
ligating molecules such as alcohols,30 sugars31 and silanols.32
SABRE hyperpolarised molecules with MR signals responsive
to factors such as pH 33,34 NO concentration35 or H2O2
36 have
been reported.
Considering the importance that hyperpolarization tech-
niques can have for the potential development of molecular
fMRI approaches, in this work we aimed to combine the areas
of bio-responsive MR probes and SABRE hyperpolarisation.
Namely, we sought to explore SABRE on prototype responsive
agents, which contain Ca-binding chelators appended with
pyridyl units. Therefore, we report on the synthesis of several
probes that contain functionalities based on ethylene glycol-
bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid (EGTA), which
are known to ligate biologically relevant metal ions37,38 along-
side pyridyl rings that can bind iridium as required for SABRE
(Fig. 1).18 Moreover, we demonstrate the SABRE hyperpolaris-
ation properties of the agents synthesised here and discuss a
strategy for the rational design of responsive probes with
enhanced MR signals.
Results and discussion
Design and synthesis of EGTA-based molecular probes
suitable for SABRE hyperpolarisation
Development of Ca-sensitive hyperpolarized 13C and 15N con-
trast agents for MRI using the d-DNP technique has been
reported recently.37,39,40 One of these hyperpolarisation
approaches has been applied to 13C-EGTA, which is similar to
the ligands used in this work. In this example, changes in
hyperpolarised 13C-labelled carboxylate chemical shifts in
response to coordination to various metals including calcium,
magnesium and zinc were reported.37 Here, we did not use 13C
or 15N isotopically labelled molecules to improve the NMR
signal, but functionalised EGTA, a typical calcium binding
motif,38 with pyridyl arms to create a series of molecules
amenable to SABRE hyperpolarisation. This strategy of mole-
cular functionalisation with a pyridyl group allowed us to
create molecules compatible for SABRE hyperpolarisation and
has been applied previously to fentanyl derivatives,41 synthetic
oligopeptides42 and others.35 The relative geometry of the
pyridyl binding site and the EGTA-derived unit is expected to
play an important role in determining both metal sensitivity
and SABRE efficiency. The steric properties of the target agents
are particularly important in controlling binding affinity to
iridium, as the hyperpolarisation of bulky ligands is known to
be limited by steric repulsion between the catalyst and target
agent.43 Therefore, we prepared a set of agents that had ortho
(o), meta (m) and para (p) relationships between the pyridyl
nitrogen and the EGTA unit (Scheme 2).
The synthesis of the desired products was performed in
different 2- or 3-step procedures. Briefly, a reductive amination
procedure was used to modify a 2,2′-(ethylenedioxy)bis(ethyl-
amine) core with ortho-, meta-, or para-pyridinecarboxalde-
hydes in a step that proceeded quantitatively. The subsequent
successive alkylation of the resulting pyridyl ethanamines,
1o,m,p with tert-butyl bromoacetate was tested using several
reaction conditions. Reasonable yields of 2o,m,p were obtained
in dry acetonitrile with the base potassium carbonate and pot-
assium iodide. After their isolation and the subsequent acidic
hydrolysis of the esters, the target substrates S1m,p were crystal-
lized by slow diffusion of methanol solutions into diethyl
ether, while the acid derivative S1o was isolated as a dark-red
oil.
It has been reported that the substitution of two carboxylic
groups by amide units in EGTA significantly influences its
coordination properties and the consequent MR behaviour of
the corresponding Gd-complexes.44 Consequently, we also syn-
thesised substrate S2 to investigate whether an amide group
linking the pyridyl and EGTA units would have an effect on
SABRE. S2 was synthesised in both meta (S2m) and para (S2p)
forms in two steps by following a literature procedure with
only minor modifications (Scheme 2b).44 Finally, the substrate
S3m, which contains one pyridyl ring, was prepared in three
steps (Scheme 2c). The hydrolysis step used conditions
adapted from Zalupski et al.45 The ortho isomer of S2 (S2o) and
the ortho and para derivatives of S3 (S3o and S3p, respectively)
were not synthesised due to the prediction that they would
exhibit poor SABRE or challenging synthetic preparation.
Formation of SABRE active complexes with substrates S1 and
S2
SABRE requires an active polarisation transfer catalyst that
undergoes both pH2 and substrate exchange.
18 Typically, this
Fig. 1 Structures of the substrates used in this work. These contain Ca-binding chelators based on EGTA appended with pyridyl arms, which can
bind iridium polarisation transfer catalysts used in SABRE hyperpolarisation.
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is achieved by activating solutions containing [IrCl(COD)
(IMes)], A where COD = cis,cis-1,5-cyclooctadiene and IMes =
1,3-bis(2,4,6-trimethyl-phenyl)imidazol-2-ylidene and 4–20
equivalents (relative to Ir) of substrate with 3 bar pH2 in sol-
vents such as methanol-d4 or dichloromethane-d2. This
process typically results in the formation of catalysts of the
type [Ir(H)2(IMes)(substrate)3]Cl, which then undergo the
required ligand exchange processes needed for SABRE.18
The SABRE compatibility of substrates S1o,m,p, S2m,p and S3m
was investigated by preparing samples of [IrCl(COD)(IMes)] (A,
2.5 mM) and 4 equiv. of the substrate in 0.6 mL of methanol-
d4.
1H NMR spectra were then recorded at 298 K several hours
after the addition of 3 bar H2. These measurements revealed
in each case that hydride containing complexes form, but their
signals were extremely weak indicating poor catalyst activation
(Fig. S1, ESI†).
When the sample containing S1o was shaken with 3-bar pH2
for 10 seconds at 65 G, and then examined by high-field (9.4 T)
NMR, PHIP enhanced hydride signals were visible at δ −20.56
and −31.21 (Fig. 2a). These signals are consistent with hydride
environments trans to nitrogen- and oxygen-donor sites
respectively. It is therefore likely that they arise from a complex
of the type [Ir(H)2(IMes)(κ
2-N,O-S1o)(L)], in which S1o is bound
through N- and O-sites. This is possible due to the ortho
arrangement of the pyridyl ring and the carboxylate motif.
Related complexes containing bidentate H2NCH2COO
− and
RNC(R)COO− ligands have been reported with their hydride
resonances yielding similar chemical shifts.46,47
In contrast, when the same experiments were repeated
using S1m and S1p, hyperpolarised hydride NMR signals for
analogous [Ir(H)2(IMes)(κ
2-N,O-S1)(L)] complexes are no longer
observed. This is likely the result of the arrangement between
the pyridyl ring and the EGTA unit leading to steric strain in
such products. Consequently, S1m and S1p can no longer act as
N-,O-donors in the same way as S1o. In the case of S1m and S1p,
Fig. 2 Partial single scan 1H NMR spectra recorded at 9.4 T and 298 K
after a sample containing [IrCl(COD)(IMes)] (2.5 mM) and 4 equiv. (a) S1o
(b) S1m (c) S1p (d) S2m (e) S2p and (f ) S3m in 0.6 mL of methanol-d4 were
shaken with 3 bar pH2 for 10 seconds at 65 G.
Scheme 2 Structures of (a) S1o,m,p (b) S2m,p and (c) S3m, and a summary of their synthetic preparation: (a) (i) PyCHO, CH2Cl2, N2; (ii) NaBH4, EtOH,
0 °C, N2; (iii) BrCH2COOtBu, K2CO3, KI, DMF, N2; (iv) TFA, CH2Cl2, 0 °C, N2 (b) (i) Ac2O, CH2Cl2, N2; (ii) PyNH2, Py (or Py/DMF), N2 and (c) (i)–(iii) same
as (a), (iv) HCl, dioxane, 0 °C, N2.
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hyperpolarised signals at δ −21.30 and −23.79 are observed
instead. For S2m and S2p, the corresponding hyperpolarised
signals appear at δ −22.53 and −23.54 (Fig. 2d and e respect-
ively). The chemical shifts of these signals are characteristic of
hydride ligands lying trans to chloride19,48,49 or pyridyl
nitrogen.21,22,26–28,43,50 Therefore, these 1H NMR signals are
expected to arise from [IrCl(H)2(IMes)(N-S1–2)(L)] where L,
located cis to hydrides and trans to the NHC, is expected to
correspond to S1–2. Full NMR characterisation and structural
elucidation of these complexes was hampered by their low
NMR signal intensity, which may reflect low stability. No PHIP
enhanced hydride signals were observed using S3m suggesting
that in this case an active polarisation transfer catalyst is not
formed. We attribute this to the large steric size of S3m, which
in this case would likely prevent binding of the two S3m mole-
cules necessary to form an analogous [IrCl(H)2(IMes)(N-S3m)
(L)] complex, where L is S3m.
No NMR signal enhancements corresponding to the agents
S1o,m,p, S2p or S3m themselves are observed suggesting that
while iridium-agent complexes exhibiting PHIP enhanced
hydride resonances are formed using S1o,m,p and S2p, these
complexes do not act as SABRE polarisation transfer catalysts
in these cases. In contrast, hyperpolarised 1H NMR resonances
for the pyridyl ring of S2m were observed (Fig. 3b–d); the ortho
sites were enhanced by 16 and 13-fold relative to their
Boltzmann derived signal strengths. The more distant meta
and para 1H NMR sites were enhanced by 9 and 12-fold
respectively. The corresponding signal gains achieved at 273 K
were comparable to these, although they increased to 32, 37,
12 and 21-fold for the two ortho, meta and para sites respect-
ively at 318 K. This is likely to be the result of faster ligand
exchange and suggests the resulting complex is reasonably
stable.21,24
Use of co-ligands to form stable SABRE active complexes
Agents S1–3 reflect some of the most structurally complex mole-
cules investigated for hyperpolarisation using SABRE, which is
usually applied to low molecular weight molecules with less
than 20 atoms.23 The large size of S1–3 is likely to hamper the
formation of typical SABRE catalysts of the type [Ir(H)2(IMes)
(S1–3)3]Cl. In previous studies using sterically large targets, sub-
strate coordination can be favoured by using SABRE catalysts
with sterically smaller carbene ligands.43 The addition of a co-
ligand to support the formation of active polarisation transfer
catalysts with sterically large substrates35 or weakly donating
O-donor ligands has also been used.19,29 We therefore added
the co-ligands acetonitrile27,51 or benzylamine26,28 to see if
suitable stable polarisation transfer catalysts form with agents
S1–3.
The effect of acetonitrile was tested by its addition (0.5 µL,
and then a further 2 µL) to solutions of preactivated [IrCl
(COD)(IMes)] (A, 2.5 mM) and S1 (4 equiv.) with 3 bar H2 in
0.6 mL of methanol-d4. No change in the appearance of the
hydride region of the corresponding 1H NMR spectra were
observed when compared to the spectra observed without
addition of this co-ligand (Fig. 2). This is surprising given the
known stability of mono-substituted acetonitrile complexes of
this type27,51 and supports our earlier hypothesis that the com-
plexes formed in these cases likely do not undergo the ligand
exchange needed for SABRE.18,23,24
Therefore, as predicted, when a fresh sample was prepared
containing A (4 mM), S1m (3 equiv.), acetonitrile (2 equiv.) and
3 bar H2 in 0.6 mL of methanol-d4, a different hydride-contain-
ing complex forms, exhibiting resonances at δ −20.77 and
−22.29. These resonances are comparable to those previously
reported for [Ir(H)2(IMes)(NCCH3)(pyridine)2]Cl, which appear
at δ −20.56 and −22.12.27 The formation of an analogous
complex is supported by the observation of three sets of aro-
matic 1H NMR resonances for three distinct types of pyridyl
ring. The first of these has resonances at δ 8.79, 8.65, 7.62 and
8.17 and they match those of the free agent, S1m. Additional
sets of resonances at δ 8.43, 8.45, 7.25, 7.95 and δ 8.38, 8.72,
7.15, 7.85 are visible corresponding to the pyridyl groups of
S1m bound to iridium (Fig. 4b). 2D NMR characterisation data
for this sample confirms the relative orientation of IMes,
hydride, pyridyl and acetonitrile ligands in the immediate
coordination sphere of the metal (Table S2 in ESI† for full
characterisation details). These measurements cannot,
however, confirm whether the two distinct bound pyridyl rings
of S1m arise from the same or separate molecules of bound
Fig. 3 Partial single scan 1H NMR spectra of the aromatic region of a
sample containing (a) thermally polarised [IrCl(COD)(IMes)] (2.5 mM) and
S2m (4 equiv.) in 0.6 mL of methanol-d4 (b)–(d) the same sample after
shaking with 3 bar pH2 at 65 G for 10 seconds after being left in a ther-
mostatically controlled water bath at (b) 273 K (c) 298 K and (d) 318 K for
60 seconds prior to pH2 shaking.
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S1m. We note that high resolution mass spectrometry did not
yield molecular ion peaks corresponding to intact complexes
due to severe molecular fragmentation, even with liquid injec-
tion field desorption ionization (LIFDI) techniques. However,
the appearance of these bound aromatic 1H NMR signals
appears similar when an analogous sample is prepared using
0.9 equiv. of S1m relative to catalyst (Fig. S6, ESI†). We therefore
deduce the complex formed from S1m is [Ir(H)2(IMes)(NCCH3)
(κ2-N,N-S1m)]Cl, in which S1m acts as a bidentate ligand coordi-
nating through both pyridyl rings. We note that when a
sample of S3m (4 equiv.) and A (2.5 mM) with 3 bar pH2 in
methanol-d4 (0.6 mL) was prepared, no PHIP enhanced
hydride containing complexes were formed, which suggests
that both pyridyl rings of S1m are required to form the hydride
signals assigned as [Ir(H)2(IMes)(NCCH3)(κ
2-N,N-S1m)]Cl.
When such a sample containing S1m was shaken for 10
seconds with pH2 at 65 G, prior to recording a high-field
1H
NMR spectrum, the observed hydride resonances exhibit PHIP
enhancement (Fig. S3, ESI†). To this end, some resonances in
the aromatic region are now enhanced as a consequence of
SABRE (Fig. 4). These hyperpolarised resonances correspond
to one of the bound pyridyl rings in [Ir(H)2(IMes)(NCCH3)(κ
2-
N,N-S1m)]Cl, which must occupy a binding site trans to hydride
in order to receive polarisation transfer via SABRE.18 The 1H
NMR signal gains for the two ortho sites in this bound pyridyl
ring (labelled as o and b in Fig. 4) are enhanced by a factor of
63-fold, compared to those recorded under Boltzmann derived
conditions, although they cannot be distinguished from each
other due to overlap. Signals for the meta and para sites in this
pyridyl ring are enhanced by 3- and 53-fold respectively. Much
weaker enhancements (<10-fold) are observed for a second set
of resonances, which are attributed to a pyridyl ring that is
located cis to the hydride ligands of [Ir(H)2(IMes)(NCCH3)(κ
2-
N,N-S1m)]Cl. Due to slow exchange, only a 3-fold enhancement
is observed for the para resonance of the free agent. The NMR
signal gains for each site have been compiled and summarized
(Fig. 5 and Table S6 in ESI†).
When these SABRE measurements were repeated after
leaving the sample in a water bath at 318 K for 60 seconds,
prior to pH2 shaking and detection at 298 K, the resulting
1H
NMR signal gains were roughly double those recorded when
the shaking process was performed at 298 K (Fig. 5). In these
measurements, NMR signal gains for the 1H acetonitrile sites
were also observed (enhanced by 27- and 48-fold per proton at
298 and 318 K respectively). A hyperpolarised 13C NMR
response for acetonitrile at δ 116 could also be discerned in a
single scan when shaken in a mu-metal shield, while no
enhanced 13C signals corresponding to S1m were visible
(Fig. S4, ESI†). These enhanced acetonitrile signals are consist-
ent with its dissociation from [Ir(H)2(IMes)(NCCH3)(κ
2-N,N-
S1m)]Cl providing a route to pH2 exchange.
27,52 These results
suggest that in this system, an active SABRE catalyst of type [Ir
(H)2(IMes)(NCCH3)(κ
2-N,N-S1m)]Cl is able to catalyse polaris-
ation transfer from pH2 to S1m. However, the high relative pro-
portion of polarisation of S1m bound to iridium suggests that
exchange of this ligand is very slow.
The analogous polarisation transfer complex [Ir(H)2(IMes)
(NCCD3)(κ
2-N,N-S2m)]Cl forms when A (4 mM), S2m (3 equiv.),
acetonitrile-d3 (2 equiv.) and 3 bar H2 react in 0.6 mL of metha-
nol-d4. However, when shaken with pH2 at 298 K,
1H NMR
signal enhancements of less than 20-fold were seen for the
corresponding bound ligand resonances, which did not
improve at 273 or 318 K (see ESI, Table S3†). These signal
gains for S2m are comparable to those achieved in the absence
Fig. 4 (a) Signal averaged 1H NMR spectrum of S1m in 0.6 mL of methanol-d4 recorded at 9.4 T and 298 K (b) partial single scan
1H NMR spectrum
of a sample containing [IrCl(COD)(IMes)] (4 mM), S1m (3 equiv.) and acetonitrile (2 equiv.) in 0.6 mL of methanol-d4 recorded under Boltzmann con-
ditions at 9.4 T and 298 K (c) SABRE hyperpolarised 1H NMR spectrum after shaking the sample described in (b) with 3 bar pH2 for 10 seconds at 65
G.
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of a co-ligand. To improve the signal gains for these agents
further an active polarisation transfer catalyst needs to be
formed, which exchanges the target substrate more rapidly,
whilst reducing polarisation wastage into the acetonitrile co-
ligand.
Optimisation of SABRE enhancement of S1m by co-ligand and
catalyst variation
The optimisation of SABRE performance is typically achieved
by varying factors including the co-ligand50,53 and the carbene
ligand of the catalyst,21,54 which serve to tune pH2 and sub-
strate exchange within the active catalyst. When analogous
SABRE measurements were performed using samples contain-
ing A (4 mM), S1m (3 equiv.), and the known SABRE co-ligand
benzylamine,26,28 a major hydride containing product is
formed with signals at δ −22.25 and −22.80. This species is
expected to correspond to the related [Ir(H)2(IMes)(κ
2-N,N-S1m)
(ND2CH2Ph)]Cl; as whilst these measurements start with
NH2CH2Ph, rapid H/D exchange in methanol-d4 forms
ND2CH2Ph.
28 When these samples were shaken with pH2,
SABRE enhancements for the pyridyl groups of S1m bound
within the catalyst were again observed; however, the effect is
now much smaller than when acetonitrile was used as the co-
ligand (Fig. 5). In these measurements, the presence of
additional pyridyl resonances from the amine complicates
spectral interpretation due to peak overlap. In fact, hyperpol-
arised signals for the pyridyl ring coordinated cis to hydrides
are no longer discerned. In these cases, a more significant
enhancement of the free para resonance of S1m is achieved
(52-fold with benzylamine compared to 3-fold for acetonitrile),
which does not increase at elevated temperatures.
Deuteration of 1H sites in co-ligands, catalyst, or of target
molecules, is often employed to optimise SABRE signal gains
by preventing unwanted polarisation leakage and reducing
relaxation.21,22 Catalyst design has also been used to fine tune
substrate exchange rates with bulkier carbene ligands generally
giving faster exchange.21,54 In order to encourage faster
exchange of S1m within the active [Ir(H)2(NHC)L(κ
2-N,N-S1m)]Cl
species, the bulkier iridium precatalysts B and C (Scheme 1)
were used. Analogous samples were prepared containing B or
C (4 mM), acetonitrile-d3 (2 equiv.) and S1m (3 equiv.) with 3
bar H2 in 0.6 mL of methanol-d4. Upon shaking mixtures con-
taining precatalyst B with pH2 at 298 K, total
1H signal
enhancements per proton for the pyridyl resonances of S1m
free in solution and bound to the SABRE catalyst were esti-
mated. These are now much higher at 49- and 43-fold, respect-
ively, when compared to 3- and 26-fold, respectively, using
catalyst A (see above). Similar increases relative to A were
observed when catalyst C was used (total 1H NMR signal
enhancements per proton of 19- and 117-fold for free and
bound S1m, respectively). Interestingly, while precatalyst B
gives the highest response for the free agent (an enhancement
of 72-fold is observed for one of the free ortho sites), C gives
higher signal gains for the bound agent (signal enhancements
of 350-, 138- and 211-fold were observed for the two ortho and
para pyridyl sites of S1m bound trans to the hydrides in the
SABRE polarisation transfer catalyst, respectively). This
suggests that the use of precatalysts B and C can yield more
efficient SABRE hyperpolarisation of S1m relative to A. This is
likely the effect of incorporation of the deuterium labels,
which are expected to reduce relaxation in the active catalyst.22
The greater proportion of polarisation on the bound ligand
using C suggests that polarisation transfer or hydrogen
Fig. 5 SABRE 1H NMR signal enhancements for S1m (3 equiv.) when shaken with precatalyst A (4 mM), the indicated co-ligand (2 equiv.) and 3 bar
pH2 in 0.6 mL of methanol-d4 for 10 seconds at 65 G. For measurements recorded at 273 K and 318 K the samples were placed in a thermostatically
controlled water bath for 60 seconds prior to pH2 shaking and detection at 298 K. For individual sites, signal enhancements lower than 25-fold were
omitted for clarity. A full table showing all signal enhancements for all sites, including errors, is given in the ESI Table S6.† Note that resonances
omitted from the figure gave no signal enhancements. The structure of the NHC ligand and substrate S1m are shown in Scheme 1 and Fig. 1
respectively.
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exchange within C is more efficient, but that relaxation or sub-
strate exchange effects are less optimal compared to B. These
signal gains are summarised in Fig. 5 and Table 1 (the
Table S6 in ESI† contains a full table of signal enhancements).
Comparison of SABRE efficiency of S1–3
Signal enhancements of S1o, S1p, S2p and S3m were also
recorded under the same conditions as those which gave the
highest signal enhancements for S1m. This involved shaking
samples containing precatalyst C (4 mM), acetonitrile-d3 (2
equiv.) and substrate (3 equiv.). SABRE performance of S2m (3
equiv.) was tested for a sample containing C (4 mM) with 3 bar
pH2 in methanol-d4 (0.6 mL). No co-ligand was used in this
case as our previous tests (see above) found comparable signal
enhancements for conditions with and without acetonitrile for
this agent. Under these conditions, precatalyst C delivers
45-fold 1H NMR signal gain for one of the ortho sites of free
S2m at 318 K (Table 1) which is slightly higher than the largest
signal gain (37-fold) for the equivalent site at the same temp-
erature using precatalyst A (2.5 mM).
For the remaining agents that were tested in the presence of
acetonitrile-d3, total hyperpolarised
1H NMR responses for the
free agent S1o are 20-fold. Interestingly, the hydride region of
these NMR spectra reveal the presence of PHIP enhanced signals
at δ −20.16, −20.75, −28.58 and −31.31 (Fig. S21, ESI†). This
result suggests that even in the presence of this co-ligand, S1o can
bind through both N and O sites to likely form [Ir(H)2(IMes)(κ
2-N,
O-S1o)(CH3CN)], which may hamper its SABRE efficiency.
Interestingly, S1p performs well under these conditions as
the ortho and meta 1H NMR resonances of the free agent are
enhanced at 298 K by 138- and 68-fold respectively. These
signal gains are higher than those achieved under analogous
conditions for S1m free in solution (corresponding sites <30-
fold). 1H NMR signal enhancements can be increased to 159-
and 92-fold for the ortho and meta resonances, respectively, for
free S1p when polarisation transfer takes place at 273 K. A
summary of these 1H NMR signal gains is presented in Table 1
(a full table showing the NMR signal gains for each site is pre-
sented in the Table S8 in ESI†). There are no visible hyperpol-
arised signals for S1p bound to the catalyst, which suggests
that polarisation transfer efficiency or hydrogen exchange
using catalyst C must be less efficient for S1p compared to
using agent S1m.
In contrast, SABRE 1H NMR signal gains for free S2p were
low (<10-fold for the ortho site). Enhancements for the bound
ligand were much higher at 77-fold suggesting that in this case
polarisation transfer and ligand exchange processes are less
efficient in comparison to S1m and S1p. The presence of a
dominant PHIP enhanced hydride product at δ −20.9 and
−22.2 appears when S1m, S1p, or S2p are used (Fig. S21, ESI†),
which suggests that these differences in SABRE efficiency for
each agent are not due to a change in the identity of the active
magnetisation transfer catalyst.
We also note that tests involving the mono-pyridyl contain-
ing agent, S3m, did not yield discernible signals for any
hydride containing complexes and no enhanced 1H NMR
signals were observed. This suggests that while the presence of
two pyridyl rings in agents S1–2 may lead to slow exchange
kinetics, it appears that both pyridyl rings in the sterically
large agents reported in this work are important for ligation to
form SABRE active complexes.
Conclusions
In this work we prepared and studied a series of novel agents
that contain a pyridyl ring to allow hyperpolarisation using
SABRE and a metal ligating unit derived from EGTA. The intro-
duction of the pyridyl motif allows the prepared agents to coor-
dinate to the iridium SABRE polarisation transfer catalyst. The
hydride ligands of the resultant complexes were enhanced by
parahydrogen and in the case of agent S2m up to 33-fold
enhancement is achieved for 1H sites of the free pyridyl ring.
SABRE active complexes of the form [Ir(H)2(NHC)(NCCH3)
(κ2-N,N-S1–2)]Cl can be formed using agents S1m, S1p, and S2p
when acetonitrile was used as a co-ligand. We find that 1H
NMR signal gains of S1m can be increased by using bulkier cat-
alysts and in some cases increasing the temperature to encou-
rage substrate exchange and deuteration of the catalyst and co-
ligand to reduce polarisation wastage. 1H NMR signal gains of
72-fold for the ortho pyridyl site of free S1m can be achieved
using precatalyst B, although higher 1H NMR signal gains of
up to 350-fold can be achieved for pyridyl sites bound to pre-
Table 1 Summary of the highest 1H NMR signal gains for these agents achieved using SABRE and the polarisation conditions. See ESI† for full struc-
tures of the agents, site labels and full tables of signal gains for all sites
Agent
(3 equiv.)













S1o C CD3CN 318 25 ± 3 0 30 ± 2 (o) 0
S1m B CD3CN 298 49 ± 3 43 ± 3 72 ± 3 (o) 111 ± 6 (p′)
S1m C CD3CN 298 19 ± 1 117 ± 6 30 ± 1 (o, overlaps with o″) 350 ± 21 (b′ or o′)
S1p C CD3CN 273 127 ± 19 0 159 ± 20 (o) 0
S2m C None 318 33 ± 5 0 45 ± 8 (b) 0
S2p C CD3CN 298 5 ± 1 77 ± 3 5 ± 1 (o) 124 ± 6 (o′)
S3m C CD3CN 298 0 0 0 0
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catalyst C. We find that in many cases 1H NMR signal gains for
agents bound to the catalyst were much higher than those free
in solution, which indicates slow ligand exchange and is
perhaps expected given the large nature of these ligands and
their ability to act as bidentate donors. Nevertheless, the mole-
cules tested here reflect some of the sterically largest targets to
be hyperpolarised using SABRE and 1H NMR signal gains of
up to 159-fold are observed for the ortho pyridyl sites of S2m
free in solution. We note that, to the best of our knowledge,
the largest molecules successfully hyperpolarised using SABRE
have molecular masses of 337 Da,41 and ∼320 Da,35,42 both
lower than the molecules reported in this work (<471 Da).
Furthermore, this work presents a rational to design func-
tional molecules that can be hyperpolarised using SABRE. The
obtained results indicate that an ortho relationship between
the pyridyl nitrogen atom and the EGTA unit should be
avoided, as agents with this steric arrangement can act as mixed
N-,O- donors to form [Ir(H)2(IMes)(κ
2-N,O-S1o–2o)(L)] with
reduced SABRE activity, even in the presence of a co-ligand. For
the large substrates presented in this work, it appears the pres-
ence of two pyridyl rings is necessary for SABRE, as mono-
pyridyl containing S3m was not found to form any PHIP or
SABRE active iridium adducts. We therefore highlight the
tension between inclusion of iridium ligating groups to form
SABRE active complexes, and labile exchange kinetics. We find
no inherent significant difference in SABRE efficiency of meta
(S1m, S2m) or para (S1p, S2p) substituted agents, which is consist-
ent with other studies.42 Generally, higher 1H NMR signal gains
for agents S1m,p compared to S2m,p suggest that the increase in
agent size upon inclusion of an additional amide linker group
is not advantageous for SABRE hyperpolarisation.
However, it should be concluded that SABRE efficiency for
all substrates strongly varies due to their various structural, as
well as coordination, properties and exchange rates with the
SABRE catalyst. Therefore, it is likely that different polarisation
conditions (catalyst, co-ligand, concentration etc.) will have to
be applied for each agent; this would require further optimi-
sation, including increased pH2 pressure or the use of related
catalysts that have recently allowed the coordination of steri-
cally larger43,50 or weakly coordinating19,29 substrates to
increase the NMR signal gain. Removal of the SABRE catalyst
will be required before any in vivo applications; the routes for
its separation,55,56 and the development of water soluble cata-
lysts, have already been reported.57 Parallel progress in these
areas will be required to produce a wider range of molecules
whose MR signal(s) can respond to biological conditions.
Consequently, the application of SABRE hyperpolarisation to
address emerging molecular imaging questions could become
feasible in the future.
Experimental section
General remarks
Materials. 2,2′-(Ethylenedioxy)bis(ethylamine) was pur-
chased from TCI Europe (Zwijndrecht, Belgium). tert-Butyl (2-
(2-(2-aminoethoxy)ethoxy)ethyl)carbamate was purchased from
Fisher Scientific (Germany). Ethylene glycol-bis(β-aminoethyl
ether)-N,N,N′,N′-tetraacetic acid, pyridinecarboxaldehydes,
other chemicals and solvents were purchased from Merck
(Sigma-Aldrich). The chemicals were used as received unless
otherwise stated. Column chromatography was performed
using silica gel 60 (0.03–0.2 mm) from Carl Roth (Germany).
Low resolution mass spectra were recorded on an ion trap SL
1100 system Agilent with an electrospray ionization source.
High resolution mass spectra were recorded on a Bruker
Daltonics APEX II (FT-ICR-MS) with an electrospray ionization
source. NMR characterization of S1–3, and synthetic precursors,
was performed on a 300 MHz Bruker Avance spectrometer,
while all other NMR measurements were carried out on a
400 MHz Bruker Avance III spectrometer using solutions at
room temperature (298 K) unless otherwise stated. Processing
of NMR spectra was performed using TopSpin (Bruker GmbH)
and ACD/SpecManager 9.0 (Advanced Chemistry Development,
Inc.) software.
General procedure for reductive amination to form 1
2,2′-(Ethylenedioxy)bis(ethylamine) (13.5 mmol) was placed
into a Schlenk flask with activated molecular sieves (3 Å)
under a stream of nitrogen. Dry CH2Cl2 (15 mL) was added via
a rubber septum. To the resulting solution, a pyridinecarboxal-
dehyde (28.3 mmol, 2.1 equiv.) was added dropwise. The flask
was sealed with parafilm and the mixture was left stirring at
room temperature under nitrogen for 18–20 h. The progress of
the reaction was monitored by mass spectrometry and TLC
analysis. After the reaction was completed, the mixture was fil-
tered through a Celite layer and the solvent was distilled on a
rotary evaporator untill dry.
The flask with the residue was flushed with nitrogen and
dry EtOH (15 mL) was added. The mixture was cooled in an ice
bath. To the resulting solution, sodium borohydrate
(56.7 mmol, 4.2 equiv.) was added in portions. After stirirng
for ∼1 hour, the ice bath was removed and the mixture was left
stirring at room temperature overnight. The mixture was fil-
tered through a glass filter and the solvent was evaporated.
The residue was washed with water, extracted with CH2Cl2 (5–6
× 40 mL), and dried over sodium sulfate. The inorganic salt
was filtered, solvent evaporated, and the oily product dried on
a high-vacuum pump. The purity of the so-obtained precursors
1 (according to NMR analysis) was found appropriate to con-
tinue without additional purification.
N,N′-(2-Pyridylmethyl)(ethylenedioxy)bis(ethylamine) (1o).
The product was obtained as yellow oil in 89% yield. The spec-
troscopic characteristics were in agreement with the previously
reported data.58 1H NMR (CDCl3) δ 2.83–2.86 (t, J = 5.2 Hz,
CH2–NH, 4H), 3.61–3.68 (m, O–CH2, 8H), 3.96 (s, O–CH2–CH2–
NH, 4H), 7.14–7.18 (t, J = 6.14 Hz, (C–CH–CH)Py, 2H), 7.34–7.37
(d, J = 7.74 Hz, (C–CH–CH)Py, 2H), 7.61–7.67 (td, J1 = 7.55 Hz, J2
= 1.70 Hz, (N–CH–CH)Py, 2H), 8.53–8.54 (d, J = 4.15 Hz, (N–CH–
CH)Py, 2H).
13C NMR (CDCl3) δ 48.6 (O–CH2–CH2–NH), 54.7
(CH2–NH), 70.2 (O–CH2–CH2–NH, O–CH2), 122.1 ((N–CH–
Dalton Transactions Paper














































































































CH)Py), 122.5 ((C–CH–CH)Py), 136.6 ((C–CH–CH)Py), 149.2 ((N–
CH–CH)Py), 158.9 ((CH–C–N)Py).
N,N′-(3-Pyridylmethyl)(ethylenedioxy)bis(ethylamine) (1m).
The product was obtained as orange oil in 93% yield. 1H NMR
(CDCl3) δ 2.77–2.81 (t, J = 5.2 Hz, CH2–NH, 4H), 3.58–3.62 (m,
O–CH2, 8H), 3.80 (s, O–CH2–CH2–NH, 4H), 7.21–7.26 (dd, J1 =
4.91 Hz, J2 = 2.83 Hz, (C–CH–CH)Py, 2H), 7.66–7.69 (d, J = 7.93
Hz, (C–CH–CH)Py, 2H), 8.47–8.49 (dd, J1 = 4.91 Hz, J2 = 1.70 Hz,
(C–CH–N–CH)Py, 2H), 8.55–8.56 (d, J = 2.08 Hz, (C–CH–N)Py,
2H). 13C NMR (CDCl3) δ 48.6 (O–CH2–CH2–N), 51.0 (CH2–N),
70.2 (O–CH2–CH2–N), 70.4 (O–CH2), 123.3 ((C–CH–CH)Py),
135.6 ((C–CH–N)Py), 135.7 ((C–CH–CH)Py), 148.3 ((C–CH–N–
CH)Py), 149.6 ((C–CH–N)Py). HR-MS (ESI): calculated for
C18H27N4O2
+ m/z 331.2129 {M + H+}+, found 331.1953.
N,N′-(4-Pyridylmethyl)(ethylenedioxy)bis(ethylamine) (1p).
The product was obtained as yellow oil in 91% yield. 1H NMR
(CDCl3) δ 2.77–2.81 (t, J = 5.1 Hz, CH2–NH, 4H), 3.60–3.62 (m,
O–CH2, 8H), 3.81 (s, O–CH2–CH2–NH, 4H), 7.25–7.27 (d, J = 5.3
Hz, (C–CH)Py, 4H), 8.51–8.53 (dd, J1 = 4.53 Hz, J2 = 1.51 Hz, (N–
CH)Py, 4H).
13C NMR (CDCl3) δ 48.7 (O–CH2–CH2–N), 52.5
(CH2–N), 70.3 (O–CH2–CH2–N), 70.5 (O–CH2), 122.9 (C–CH)Py,
149.4 (C–CH)Py, 149.7 (N–CH)Py. HR-MS (ESI): calculated for
C18H26N4NaO2
+ m/z 353.1948 {M + Na+}+, found 353.1953.
General procedure for alkylation of 1 to form 2
The flask containing diamine 1 (7.8 mmol) was flushed with
nitrogen and dry DMF (40 mL) was added. Then potassium
carbonate (62.6 mmol, 8 equiv.) and potassium iodide
(4.7 mmol, 0.6 equiv.) were added under a stream of nitrogen.
To the resulting mixture, t-butyl bromoacetate (31.3 mmol, 4
equiv.) was added dropwise in four portions. The flask was
sealed with parafilm and left stirring at room temperature for
24 h. DMF was dried on a high-vacuum pump. The residue
was dissolved in MeOH and dried with silica gel in vacuo. The
derivatives 2o,m,p were isolated using column chromatography
on silica gel with gradient solvent mixtures: EtOAc/10%
hexane, EtOAc, EtOAc + 1.5% EtOH.
N,N′-[(tert-Butoxycarbonyl)methyl]-N,N′-(2-pyridylmethyl)
(ethylenedioxy)bis(ethylamine) (2o). The product was obtained
as dark-red oil in 57% yield. 1H NMR (CDCl3) δ 1.46 (s, C–CH3,
18H), 2.91–2.95 (t, J = 5.4 Hz, CH2–N, 4H), 3.41 (s, CO–CH2,
4H), 3.52–3.59 (m, O–CH2, 8H), 4.01 (s, O–CH2–CH2–N, 4H),
7.14–7.18 (t, J = 4.91 Hz, (C–CH–CH)Py, 2H), 7.56–7.58 (d, J =
7.55 Hz, (C–CH–CH)Py, 2H), 7.64–7.69 (t, J = 7.55 Hz, (N–CH–
CH)Py, 2H), 8.53–8.54 (d, J = 4.53 Hz, (N–CH–CH)Py, 2H).
13C
NMR (CDCl3) δ 28.2 (C–CH3), 53.4 (O–CH2–CH2–N), 56.6 (CH2–
N), 60.4 (CO–CH2), 69.9 (O–CH2–CH2–N), 70.2 (O–CH2), 80.9
(C–CH3), 122.0 ((N–CH–CH)Py), 123.1 ((C–CH–CH)Py), 136.7
((C–CH–CH)Py), 148.7 ((N–CH–CH)Py), 159.6 ((CH–C–N)Py),
170.7 (CO–CH2). HR-MS (ESI): calculated for C30H46N4NaO6
+
m/z 581.3310 {M + Na+}+, found 581.3312.
N,N′-[(tert-Butoxycarbonyl)methyl]-N,N′-(3-pyridylmethyl) (ethy-
lenedioxy)bis(ethylamine) (2m). The product was obtained as a
dark-orange oil in 58% yield. 1H NMR (CDCl3) δ 1.46 (s, C–
CH3, 18H), 2.86–2.90 (t, J = 5.5 Hz, CH2–N, 4H), 3.32 (s, CO–
CH2, 4H), 3.59 (s, O–CH2, 8H), 3.91 (s, O–CH2–CH2–N, 4H),
7.26–7.30 (dd, J1 = 7.74 Hz, J2 = 4.91 Hz, (C–CH–CH)Py, 2H),
7.75–7.77 (d, J = 7.74 Hz, (C–CH–CH)Py, 2H), 8.50–8.55 (m, (C–
CH–N)Py, (C–CH–N–CH)Py, 4H).
13C NMR (CDCl3) δ 28.1 (C–
CH3), 53.2 (O–CH2–CH2–N), 55.8 (CO–CH2), 55.9 (CH2–N), 69.3
(O–CH2–CH2–N), 70.0 (O–CH2), 81.3 (C–CH3), 123.4 ((C–CH–
CH)Py), 134.0 ((C–CH–N)Py), 137.1 ((C–CH–N)Py), 148.4 ((C–CH–
N–CH)Py), 150.1 ((C–CH–CH)Py), 171.0 (CO–CH2). HR-MS (ESI):
calculated for C30H46N4NaO6
+ m/z 581.3310 {M + Na+}+, found
581.3326.
N,N′-[(tert-Butoxycarbonyl)methyl]-N,N′-(4-pyridylmethyl)
(ethylenedioxy)bis(ethylamine) (2p). The product was
obtained as red oil in 65% yield. 1H NMR (CDCl3) δ 1.46 (s, C–
CH3, 18H), 2.86–2.90 (t, J = 5.7 Hz, CH2–N, 4H), 3.32–3.35 (m,
CO–CH2, 4H), 3.54–3.60 (m, O–CH2, 8H), 3.88 (s, O–CH2–CH2–
N, 4H), 7.32–7.34 (m, (C–CH)Py, 4H), 8.51–8.53 (dd, J1 = 4.53
Hz, J2 = 1.51 Hz, (N–CH)Py, 4H).
13C NMR (CDCl3) δ 28.1 (C–
CH3), 53.2 (O–CH2–CH2–N), 55.9 (CO–CH2), 57.6 (CH2–N), 70.0
(O–CH2–CH2–N), 70.2 (O–CH2), 80.93 (C–CH3), 123.6 (C–CH)Py,
149.2 (C–CH)Py, 149.3 (N–CH)Py, 170.6 (CO–CH2). HR-MS (ESI):
calculated for C30H46N4NaO6
+ m/z 581.3310 {M + Na+}+, found
581.3311.
General procedure for acidic hydrolysis of 2 to form S1
A solution of corresponding derivative 2 (0.48 mmol) in
CH2Cl2 (6 mL) was flushed with nitrogen, cooled down in an
ice-bath, and cold TFA (3.5 mL) was added dropwise. The pro-
gress of the reaction was monitored by mass spectrometry and
TLC analysis. In the case of the diacid S1m, an additional
amount of TFA (0.5 mL) was required to complete the process.
The solvents were removed using a rotary evaporator. MeOH
was then added to the residue, and the solution was dried in
vacuo. The procedure was repeated multiple times in order to
remove the remaining TFA.
N,N′-(2-Pyridylmethyl)(ethylenedioxy)bis(ethylamine)-N,N-
diacetic acid (S1o). The product was obtained as dark-red
sticky oil in 64% yield. 1H NMR (D2O) δ 3.43 (s, O–CH2–CH2–N,
4H), 3.57 (s, CO–CH2, 4H), 3.76 (s, O–CH2, 8H), 4.50 (s, CH2–
Py, 4H), 7.41–7.48 (m, (C–CH–CH)Py, (N–CH–CH)Py, 4H),
7.83–7.88 (t, J = 7.74 Hz, (C–CH–CH)Py, 2H), 8.52 (s, (N–CH–
CH)Py, 2H).
13C NMR (CD3OD) δ 55.5 (O–CH2–CH2–N), 57.9
(CH2–N), 59.7 (CO–CH2), 66.8 (O–CH2–CH2–N), 71.6 (O–CH2),
125.3 ((N–CH–CH)Py), 125.5 ((C–CH–CH)Py), 139.2 ((C–CH–
CH)Py), 150.5 ((N–CH–CH)Py), 152.7 ((CH–C–N)Py), 170.7
(CO2H). HR-MS (ESI): calculated for C22H31N4O6
+ m/z 447.2238
{M + H+}+, found 447.2243.
N,N′-(3-Pyridylmethyl)(ethylenedioxy)bis(ethylamine)-N,N-
diacetic acid (S1m). The product was crystallized as a proto-
nated salt (as evidenced from NMR spectra) by slow diffusion
of methanolic solution into Et2O and isolated as a fine dark-
red solid in 57% yield. 1H NMR (CD3OD) δ 3.33–3.35 (s, O–
CH2–CH2–N, 4H), 3.66 (s, O–CH2, 4H), 3.80–3.83 (t, J = 4.53 Hz,
O–CH2–CH2–N, 4H), 3.87 (s, CO–CH2, 4H), 4.46 (s, CH2–Py,
4H), 7.71–7.75 (dd, J1 = 5.29 Hz, J2 = 2.46 Hz, (C–CH–CH)Py,
2H), 8.28–8.31 (d, J = 7.93 Hz, (C–CH–CH)Py, 2H), 8.70–8.72 (d,
J = 4.53 Hz, (C–CH–N–CH)Py, 2H), 8.85 (s, (C–CH–N)Py, 2H).
13C
NMR (CD3OD) δ 55.0 (O–CH2–CH2–N), 55.6 (CO2H–CH2), 57.2
Paper Dalton Transactions














































































































(CH2–N), 67.8 (O–CH2–CH2–N), 71.3 (O–CH2), 126.4 ((C–CH–
CH)Py), 132.9 ((C–CH–N)Py), 143.3 ((C–CH–N)Py), 148.2 ((C–CH–
N–CH)Py), 149.5 ((C–CH–CH)Py), 171.3 (CO2H). HR-MS (ESI):
calculated for C22H31N4O6
+ m/z 447.2238 {M + H+}+, found
447.2241.
N,N′-(4-Pyridylmethyl)(ethylenedioxy)bis(ethylamine)-N,N-
diacetic acid (S1p). The product was crystallized by slow
diffusion of methanolic solution into Et2O and isolated as
dark-red solid in 43% yield. NMR (CD3OD) δ 3.20 (s, O–CH2–
CH2–N, 2H), 3.64–3.70 (m, CO–CH2, O–CH2, CH2–Py, 8H),
3.75–3.79 (m, O–CH2–CH2–, O–CH2–CH2–NH
+, CO–CH2, 8H),
4.36 (s, NH+–CH2–Py, 2H), 7.48–7.59 (m, (C–CH)Py, 1H), 7.81 (s,
(C–CH)Py, 3H), 8.68 (s, (N–CH)Py, 4H).
13C NMR (CD3OD) δ 55.2
(O–CH2–CH2–N), 58.6 (CO2H–CH2), 59.7 (CH2–N), 69.0 (O–
CH2–CH2–N), 70.6 (O–CH2), 126.1 (C–CH)Py, 127.4 (C–CH)Py,
150.1 (N–CH)Py, 150.7 (C–CH)Py, 179.1 (CO2H). HR-MS (ESI):
calculated for C22H31N4O6
+ m/z 447.2238 {M + H+}+, found
447.2238.
Synthesis of ethylene glycol-bis(β-aminoethyl ether)-N,N′-
diacetic-N,N′-dianhydride (EGTA-bis(anhydride)) (3). Prior to
use ethylene glycol-bis(β-aminoethyl ether)-N,N,N′,N′-tetra-
acetic acid (EGTA) was dried on a Schlenk line. A flask contain-
ing dry EGTA (0.5 g, 1.3 mmol) was filled with nitrogen, and
freshly distilled dry pyridine (6 mL) was added via a septum.
The mixture was purged with nitrogen for 15 min after which
the flask was transferred to an oil bath and the temperature
increased to 65 °C. To the resulting emulsion, acetic anhydride
(0.5 mL, 5.3 mmol) was added dropwise slowly in 100 μL incre-
ments. The flask was sealed and stirring at 65 °C was contin-
ued for 24 h. After reaction completion (following the progress
with mass analysis) the solvent was removed under reduced
pressure. The product was obtained as a dark-brown oil in
91% yield. 1H NMR (CDCl3) δ 2.82–2.85 (t, J = 4.91 Hz, O–CH2–
CH2–N, 4H), 3.58 (s, O–CH2, 4H), 3.61–3.65 (t, J = 4.91 Hz, O–
CH2–CH2–N, 4H), 3.69 (s, CO–CH2, 8H).
13C NMR (CDCl3) δ
53.6 (O–CH2–CH2–N), 54.9 (CO–CH2), 69.2 (O–CH2–CH2–N),
70.3 (O–CH2), 164.6 (CO–CH2).
General procedure for the synthesis of S2 derivatives
Into a Schlenk flask containing the anhydride 3 (0.5 g,
1.5 mmol), dry pyridine (4 mL) was added and the mixture was
purged with nitrogen for 15 min. In a separate Schlenk flask a
solution of the corresponding aminopyridine (0.3 g, 3.2 mmol)
in 3–4 mL of dry solvent (pyridine or DMF) was prepared. Due
to limited solubility of 4-aminopyridine in pyridine, DMF was
used in this case. The resulting solution was added to the
anhydride 3 via a rubber septum. The flask was sealed and left
stirring under nitrogen for 14 h. The solvent was removed
under reduced pressure. The residue was re-dissolved in water,
the pH was adjusted to 10 and the mixture was washed with
diethyl ether (4 × 30 mL). The aqueous fraction was dried
under reduced pressure and the residue was purified by pre-
parative HPLC.
N,N′-Bis[(3-pyridinyl)aminocarbonyl]-ethylene glycol-bis
(β-aminoethyl ether)-N,N′-diacetic acid (S2m). S2m was iso-
lated using HPLC with a 5 min linear gradient from 2 to 20%
acetonitrile followed by a 30 min linear gradient from 20 to
50%. The product was obtained as a light-brown crystalline in
42% yield. 1H NMR (D2O) δ 2.62 (s, O–CH2–CH2–N, 4H), 3.15
(s, O–CH2, 4H), 3.22–3.24 (d, J = 6.07 Hz, O–CH2–CH2–N, 4H),
3.35 (s, CO2H–CH2, CO–CH2, 8H), 7.16–7.20 (q, J1 = 4.91 Hz, J2
= 3.40 Hz, (C–CH–CH)Py, 2H), 7.72–7.75 (d, J = 8.31 Hz, (C–CH–
N–CH)Py, 2H), 8.06–8.08 (d, J = 4.72 Hz, (C–CH–CH)Py, 2H),
8.41 (s, (C–CH–N)Py, 2H).
13C NMR (D2O) δ 54.5 (O–CH2–CH2–
N), 59.2 (CO–CH2), 59.4 (CO2H–CH2), 68.3 (O–CH2–CH2–N),
69.3 (O–CH2), 124.3 ((C–CH–N)Py), 128.6 ((C–CH–CH)Py), 134.3
((C–CH–N)Py), 140.8 ((C–CH–N–CH)Py), 144.6 ((C–CH–CH)Py),
173.3 (CO–CH2), 179.1 (CO2H–CH2). HR-MS (ESI): calculated
for C24H32KN6O8
+ m/z 571.1913 {M + K+}+, found 571.1825.
N,N′-Bis[(4-pyridinyl)aminocarbonyl]-ethylene glycol-bis
(β-aminoethyl ether)-N,N′-diacetic acid (S2p). S2p was isolated
using HPLC with a 20 min liner gradient from 2 to 5% aceto-
nitrile, followed by a 5 min linear gradient from 5 to 10% and,
finally, 5 min linear gradient from 10 to 50%. The product was
obtained as a light-yellow crystalline solid in 29% yield. 1H
NMR (D2O) δ 3.03 (s, O–CH2–CH2–N, 4H), 3.48 (s, CO2H–CH2,
CO–CH2, 8H), 3.60 (s, O–CH2, 4H), 3.74 (s, O–CH2–CH2–N, 4H),
7.74 (s, (CH–CH–N)Py, 4H), 8.40 (s, (CH–CH–N)Py, 4H).
13C
NMR (D2O) δ 55.1 (O–CH2–CH2–N), 59.0 (CO–CH2), 59.2
(CO2H–CH2), 67.4 (O–CH2–CH2–N), 69.5 (O–CH2), 114.8 ((CH–
CH–N)Py), 145.4 ((CH–CH–N)Py), 149.0 ((C–CH)Py), 171.5 (CO–
CH2), 176.0 (CO2H–CH2). HR-MS (ESI): calculated for
C24H33N6O8
+ m/z 533.2354 {M + H+}+, found 533.2358.
Synthesis of N-Boc-N′-(3-pyridylmethyl)-2,2-(ethylenedioxy)
bis(ethylamine) (4). 4 was obtained in 90% yield from tert-
butyl (2-(2-(2-aminoethoxy)ethoxy)ethyl)carbamate following
the general procedure for reductive amination described
above, adapted for mono-substitution. Thus, diethylamine
(0.51 g, 2.1 mmol) and nicotinaldehyde (0.24 g, 2.2 mmol)
were dissolved in dry CH2Cl2 (10 mL) and the solution was
stirred under nitrogen for 18 h. After the work-up as described
above for 1, the residue was dissolved in absolute EtOH
(10 mL), cooled down in an ice-bath and NaBH4 (0.19 g,
5 mmol) was added in portions under a stream of nitrogen.
After the work-up as described above for 1, the product 4 was
obtained as a light-yellow oil and used without further purifi-
cation. 1H NMR (CDCl3) δ 1.44 (s, C–CH3, 9H), 2.80–2.84 (t, J =
5.1 Hz, O–CH2–CH2–NH–CH2–Py, 2H), 3.29–3.33 (m, CO–NH–
CH2, 2H), 3.52–3.55 (t, J = 5.1 Hz, O–CH2–CH2–NH, 2H),
3.61–3.65 (m, O–CH2, 6H), 3.84 (s, Py–CH2, 2H), 7.24–7.28 (dd,
J1 = 4.72 Hz, J2 = 3.02 Hz, (C–CH–CH)Py, 1H), 7.69–7.72 (d, J =
7.74 Hz, (C–CH–CH)Py, 1H), 8.49–8.51 (d, J = 4.72 Hz, (C–CH–
N–CH)Py, 1H), 8.57 (d, J = 2.08 Hz, (C–CH–N)Py, 1H).
13C NMR
(CDCl3) δ 28.4 (C–CH3), 40.3 (CO–NH–CH2), 48.5 (O–CH2–CH2–
N), 51.0 (Py–CH2), 70.2 (O–CH2), 70.3 (O–CH2–CH2–N), 79.1 (C–
CH3), 123.4 ((C–CH–CH)Py), 135.4 ((C–CH–N)Py), 135.9 ((C–CH–
CH)Py), 148.4 ((C–CH–N–CH)Py), 149.7 ((C–CH–N)Py), 156.0
(CO). HR-MS (ESI): calculated for C17H30N3O4
+ m/z 340.22308
{M + H+}+, found 340.22248.
N-[Boc-(tert-butoxycarbonyl)methyl-]-N′-[(tert-butoxycarbonyl)
methyl-(3-pyridylmethyl)]-2,2-(ethylenedioxy)bis(ethylamine) (5).
The alkylation was carried out following the general procedure
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described above for preparation of 2. The target derivative 5
was isolated using column chromatography on silica gel with
gradient solvent mixtures: hexane/EtOAc (5/3, 1/1, 1/3), EtOAc,
EtOAc + 1.5% MeOH in 73% yield. 1H NMR (CDCl3) δ
1.43–1.44 (d, J = 5.1 Hz, C–CH3, 18H), 1.47 (s, C–CH3, 9H),
2.88–2.92 (t, J = 5.67 Hz, O–CH2–CH2–N–CH2–Py, 2H),
3.30–3.33 (m, CO–N–CH2, CO–CH2–N–CH2–Py, 4H), 3.51–3.53
(d, J = 5.29 Hz, O–CH2–CH2–N–CH2–Py, 2H), 3.55–3.59 (m, O–
CH2, 6H), 3.65 (s, CO–CH2–N, 2H), 3.89 (s, Py–CH2, 2H),
7.24–7.28 (dd, J1 = 4.91 Hz, J2 = 3.02 Hz, (C–CH–CH)Py, 1H),
7.73–7.76 (d, J = 7.74 Hz, (C–CH–CH)Py, 1H), 8.50–8.51 (d, J =
3.59 Hz, (C–CH–N–CH)Py, 1H), 8.59 (s, (C–CH–N)Py, 1H).
13C
NMR (CDCl3) δ 28.1 (C–CH3), 28.4 (C–CH3), 53.0 (O–CH2–CH2–
N), 53.4 (Py–CH2), 55.7 (CO–CH2–N), 56.0 (O–CH2–CH2–N–
CH2–Py), 70.0 (O–CH2–CH2–N), 70.3 (O–CH2), 81.1 (C–CH3),
123.4 ((C–CH–CH)Py), 134.9 ((C–CH–N)Py), 136.7 ((C–CH–N)Py),
148.5 ((C–CH–N–CH)Py), 150.2 ((C–CH–CH)Py), 156.1 (CO),
170.7 (CO). HR-MS (ESI): fragments calculated for C23H44N2O8
m/z 476.3092 {M + H+ − PyCH2
+}, found 476.2733; calculated
for C23H40N3O6
+ m/z 454.2912 {M + 2H+ − CH2CO2
tBu+}+,
found 454.2914.
Synthesis of N-(formic acid)-N′-(3-pyridylmethyl)-2,2-(ethyle-
nedioxy) bis(ethylamine)-N,N′-diacetic acid (S3m). Starting com-
pound 5 (0.64 g, 1.1 mM) was dissolved in dry dioxane (7 mL)
in a flask filled with nitrogen. The mixture was cooled down in
an ice bath and conc. HCl was added dropwise in 0.5 mL steps
over 30 min (3 mL in total). After 20 min the ice bath was
removed and the mixture was allowed to warm to room temp-
erature and left stirring for 4 h. The solvent was then evapor-
ated and the residue purified using HPLC with a 10 min linear
gradient from 2 to 10% acetonitrile, followed by a 5 min linear
gradient from 10 to 20%. The product S3m was obtained as a
dark-brown oil in 67% yield. 1H NMR (D2O) δ 2.83 (s, O–CH2–
CH2–N–CH2–Py, 2H), 2.99 (O–CH2–CH2–N, 2H), 3.28 (s, CO–
CH2, 2H), 3.39 (m, CO–NH–CH2, 4H), 3.45 (s, CO–CH2, 2H),
3.58 (s, O–CH2–CH2–N–CH2–Py, 2H), 3.65 (s, O–CH2–CH2–N,
2H), 3.90 (s, Py–CH2, 2H), 7.85 (m, (C–CH–CH)Py, 1H),
8.49–8.52 (d, J = 7.37 Hz, (C–CH–CH)Py, 1H), 8.59 (s, (C–CH–N–
CH)Py, 1H), 8.73 (s, (C–CH–N)Py, 1H).
13C NMR (D2O) δ 39.0 (O–
CH2–CH2–N), 46.8 (N–CH2–CO2H), 47.3 (CO–NH
+
–CH2), 54.2
(O–CH2–CH2–N–CH2–Py), 55.0 (CO2H–CH2–N–CH2–Py), 64.2
(Py–CH2), 65.1 (O–CH2–CH2–N), 66.1 (O–CH2–CH2–N–CH2–Py),
69.3 (O–CH2), 128.0 ((C–CH–CH)Py), 128.9 ((C–CH–N)Py), 142.7
((C–CH–N)Py), 143.5 ((C–CH–N–CH)Py), 150.0 ((C–CH–CH)Py),
168.1 (NH+–CO), 168.6 (CO2H). HR-MS (ESI): calculated for
C17H22N3O7
2•− m/z 380.3736 {M − 2H − OH}2•−, found
380.7067.
SABRE procedures
Parahydrogen (pH2) was produced by passing hydrogen gas
over a spin-exchange catalyst (Fe2O3) and used for all hyperpol-
arisation experiments. This method produces constant pH2
with ca. 98% purity. 1H (400 MHz) and 13C (100.6 MHz) NMR
spectra were recorded with an internal deuterium lock.
Chemical shifts are quoted as parts per million and referenced
to the solvent. 13C NMR spectra were recorded with broadband
proton decoupling. Coupling constants ( J) are quoted in Hertz.
Samples were prepared in a 5 mm NMR tube that was fitted
with a J. Young’s tap. [IrCl(COD)(IMes)] was synthesized
according to a literature procedure.59 The resulting solutions
were degassed by two freeze–pump–thaw cycles before the
addition of 3-bar H2.
The shake and drop method was employed for recording
hyperpolarised NMR spectra. This involves filling NMR tubes
with pH2 at 3 bar pressure and shaking them vigorously for 10
seconds in a 65 G magnetic field (stray field of the 9.4 T
spectrometer). Typically, three shake and drop measurements
are recorded and average 1H NMR signal enhancement values
are quoted. The typical variation among these measurements
is <±10%. Signal enhancements are calculated by dividing the
integrated signal intensities from a single scan hyperpolarised
spectrum by its thermal counterpart recorded under the same
spectral conditions. These values are presented per fold, i.e. a
100-fold enhancement means that hyperpolarised signals are
100 times more intense than those recorded using Boltzmann
controlled NMR.
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